Company Facing Puberty Blocker Probe Gave Pediatric Endocrine Society $125k+
The Pediatric Endocrine Society (PES) has received over $125k between 2017 and 2021 from AbbVie, a pharmaceutical company that is under investigation in Texas and produces a drug commonly used as a puberty blocker.